title: Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction.
authors.affiliation: Department of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges University, Yichang 443000, Hubei Province, China; Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, Hubei Province, China.
authors.forename: Chao-Jun
authors.initials: CJ
authors.lastname: Yang
authors.affiliation: Department of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges University, Yichang 443000, Hubei Province, China; Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, Hubei Province, China. Electronic address: yangjun@ctgu.edu.cn.
authors.forename: Jun
authors.initials: J
authors.lastname: Yang
authors.affiliation: Department of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges University, Yichang 443000, Hubei Province, China; Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, Hubei Province, China.
authors.forename: Jian
authors.initials: J
authors.lastname: Yang
authors.affiliation: Department of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges University, Yichang 443000, Hubei Province, China; Institute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, Hubei Province, China.
authors.forename: Zhi-Xing
authors.initials: ZX
authors.lastname: Fan
mesh_terms: D015316:Genetic Therapy; D006801:Humans; D059630:Mesenchymal Stem Cells; D009203:Myocardial Infarction / Q000628:therapy; D033581:Stem Cell Transplantation; D013879:Thioredoxins
chemical_list: D013879:Thioredoxins